Plocabulin - CISMeF

Preferred Label : Plocabulin;

NCIt definition : A marine-derived, synthetically produced compound with potential antineoplastic activity. Plocabulin covalently binds to residues lying in the minor groove of DNA, which may result in delayed progression through S phase, cell cycle arrest in the G2/M phase and cell death.;

UNII : 52Y8L60CR7;

InChIKey : IEKGSKLKBICCHQ-BDOJOPHNSA-N;

CAS number : 960210-99-5; a href https://gsrs.ncats.nih.gov/ginas/app/beta/browse-substance?search 960210-99-5 alt lien vers site G-SRS target _blank img src /img/logos/logo_g-srs.png alt Logo G-SRS /a ;

Molecule name : PM-060184;

Details

Origin ID

C95888;

UMLS CUI

C4727601;

Automatic exact mappings (from CISMeF team)
- plocabulin [MeSH Supplementary Concept]
Currated CISMeF NLP mapping
- plocabulin [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
UMLS correspondences (same concept)
- PM060184 [MeSH concept]
- plocabulin [MeSH Supplementary Concept]
concept_is_in_subset
- CTRP Agent Terminology [NCIt concept]
- CTRP Terminology [NCIt concept]
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]
- GDC Terminology [NCIt concept]
- GDC Therapeutic Agent Terminology [NCIt concept]
- GDC Value Terminology [NCIt concept]
- NCI Drug Dictionary Terminology [NCIt concept]
- NCIt Antineoplastic Agent Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients